ALTONA DIAGNOSTICS
LIVE

Serial Number

79184031

Owner

altona Diagnostics GmbH

Attorney

Matthew J. Smith

Filing Date

Oct 6, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ALTONA DIAGNOSTICS Trademark

Serial Number: 79184031 • Registration: 5139471

ALTONA DIAGNOSTICS is a trademark filed by altona Diagnostics GmbH on October 6, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

altona Diagnostics GmbH (6 trademarks)

Mörkenstraße 12

Entity Type: 99

Trademark Details

Filing Date

October 6, 2015

Registration Date

February 14, 2017

Published for Opposition

November 29, 2016

Goods & Services

Scientific research; Scientific and technological services, namely, technical research, scientific research in the field of molecular biology; development of computer hardware and software; consultancy services for scientific purposes, namely, consulting in the fields of biotechnology, laboratory testing, and diagnostics; technological laboratory consultancy services, namely, consulting in the field of laboratory testing, scientific laboratories, and medical laboratories; clinical and medical laboratory services; medical research; biochemical research and development

Biological preparations for use in sample preparation and pathogen detection other than for medical or veterinary use; biological substances and chemical preparations, namely reagents for isolation and purification of nucleic acids, in vitro diagnostic test reagents, and control standards for scientific and research purposes; diagnostic reagents for use in identifying pathogens for scientific and research use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for scientific and research use; chemical substances for analysis in scientific and laboratory research, other than for medical or veterinary purposes; chemicals for use in industry

Pharmaceutical and veterinary preparations namely biological substances and chemical preparations for use in medical scientific and medical research purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic test reagents and control standards for medical diagnostic use or veterinary use; diagnostic preparations for clinical and medical use; diagnostic reagents for use in identifying pathogens for clinical and medical use; diagnostic kits consisting primarily of diagnostic reagents for use in identifying pathogens for clinical and medical use; biological preparations for the treatment of cancer; chemical preparation for the diagnosis of pregnancy

Scientific apparatus and instruments for laboratory use and for the conducting and evaluation of diagnostic examinations for medical purposes, namely, fluid handling devices, pipetting workstation, sensing and signaling devices for measurement and quality control of materials; medical laboratory research instruments for DNA analysis, RNA analysis; computers; data processing apparatus and parts thereof; data processors; computer software programs for controlling laboratory equipment for the isolation and purification of nucleic acids: computer hardware and software systems for in vitro diagnostic or scientific research use, namely electronic systems comprising fluid handlers, plate readers, vial readers, bar code reader, control software, designed for isolation and purification of nucleic acids, set up reaction mixes for polymerase chain reaction (PCR) and PCR thermal cyclers

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 15, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Sep 4, 2025 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Jan 27, 2024 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sep 3, 2023 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Sep 3, 2023 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 2, 2023 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 13, 2023 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 14, 2022 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 9, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2017 FICS
FINAL DISPOSITION PROCESSED
May 19, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 14, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 19, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 19, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 19, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 19, 2016 CNEA
ASSIGNED TO EXAMINER
Sep 28, 2016 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2016 TROA
REFUSAL PROCESSED BY IB
May 14, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 15, 2016 MAFR
ASSIGNED TO EXAMINER
Mar 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2016 REPR